The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Identification and characterization of essential genes in the human genome
Open accessAbstract
Zeroing in on essential human genes: More powerful genetic techniques are helping to define the list of genes required for the life of a human cell. Two papers used the CRISPR genome editing system and a gene trap method in haploid human cells to screen for essential genes (see the Perspective by Boone and Andrews). Wang et al. 's analysis of multiple cell lines indicates that it may be possible to find tumor-specific dependencies on particular genes. Blomen et al. investigate the phenomenon in which nonessential genes are required for fitness in the absence of another gene. Hence, complexity rather than robustness is the human strategy. Science , this issue p. 1096 and p. 1092 ; see also p. 1028
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Pooled CRISPR screening is a powerful and widely used method for identifying genes involved in biological mechanisms such as cell proliferation 1, 2 , drug resistance 3 , and viral infection 4 .”
From Pooled CRISPR screening with single-cell transcriptome readout. (2017) · cites this paper as [2]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Joung, J.'s team employed the SHERLOCK technique to detect SARS-CoV-2 viral RNA using the CRISPR-Cas13a system.”
From A Review of Research on CRISPR/Cas9 Gene Editing Technology in Disease Treatment (2024) · cites this paper as [17]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This assay is highly sensitive and specific, capable of detecting low concentrations of SARS-CoV-2 RNA in a short period of time [17].”
From A Review of Research on CRISPR/Cas9 Gene Editing Technology in Disease Treatment (2024) · cites this paper as [17]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Many of the identified mediator complex components were concordantly associated with resistance to other targeted cancer therapies,44,45 but were also controversially identified as essential genes in CML cells.46”
From Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia (2024) · cites this paper as [46]
Experimental — accuracy not yet measuredIn the citing paper
“we computed gene-level enrichment scores (Supplementary Fig. 4e, Supplementary Table 3), which were highly correlated with a previous genome-wide CRISPR screen in K562 cells10 (r = 0.85)”
From Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens (2021) · cites this paper as [10]
In the citing paper
“genome-scale application of CRISPR-Cas9 genome editing approaches offer the potential to map global genetic interaction networks in human cells (55–57)”
From A global genetic interaction network maps a wiring diagram of cellular function (2016) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationSystematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Lethality and centrality in protein networks
Jeong, H., Mason, S., Barabási, A., & Oltvai, Z. (2001) · Nature · doi:10.1038/35075138 · Cited by 5,327
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316
BioGRID: a general repository for interaction datasets
Stark, C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj109 · Cited by 3,960
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,005
CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer
Castells‐Roca, L., Tejero, E., Rodríguez‐Santiago, B., & Surrallés, J. (2021) · Cancers · doi:10.3390/cancers13071591 · Cited by 45
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma
Ishio, T., Kumar, S., Shimono, J., Daenthanasanmak, A., Dubois, S. P., Lin, Y., Bryant, B. R., Petrus, M. N., Bachy, E., Huang, D. W., et al. (2021) · Blood · doi:10.1182/blood.2021012734 · Cited by 41
Hemming, M. L., Benson, M. R., Loycano, M. A., Anderson, J. A., Andersen, J. L., Taddei, M. L., Krivtsov, A. V., Aubrey, B. J., Cutler, J. A., Hatton, C., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0646 · Cited by 39
Calame, D. G., Guo, T., Wang, C., Garrett, L., Jolly, A., Dawood, M., Kurolap, A., Henig, N. Z., Fatih, J. M., Herman, I., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.06.013 · Cited by 42
Genome-wide CRISPR guide RNA design and specificity analysis with GuideScan2
Schmidt, H., Zhang, M., Chakarov, D., Bansal, V., Mourelatos, H. A., Rivera, F. J. S., Lowe, S. W., Ventura, A., Leslie, C. S., & Pritykin, Y. (2025) · Genome biology · doi:10.1186/s13059-025-03488-8 · Cited by 48
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
Kießling, M. K., Schuierer, S., Stertz, S., Beibel, M., Bergling, S., Knehr, J., Carbone, W., de Vallière, C., Tchinda, J., Bouwmeester, T., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3042-2 · Cited by 49
Genetic Network Complexity Shapes Background-Dependent Phenotypic Expression
Hou, J., van Leeuwen, J. S., Andrews, B., & Boone, C. M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.05.006 · Cited by 44
Fortin, J., Tan, J., Gascoigne, K. E., Haverty, P. M., Forrest, W. F., Costa, M. R., & Martin, S. E. (2019) · Genome biology · doi:10.1186/s13059-019-1621-7 · Cited by 42
γ-tubulin as a signal-transducing molecule and meshwork with therapeutic potential
Alvarado-Kristensson, M. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0021-x · Cited by 43
New tools for old drugs: Functional genetic screens to optimize current chemotherapy
Gerhards, N. M., & Rottenberg, S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.001 · Cited by 43
Long non-coding RNAs as molecular players in plant defense against pathogens
Zaynab, M., Fatima, M., Abbas, S., Umair, M., Sharif, Y., & Raza, M. A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.050 · Cited by 43
An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation
Raffeiner, P., Hart, J. R., García-Caballero, D., Bar‐Peled, L., Weinberg, M. S., & Vogt, P. K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921786117 · Cited by 43
Alkallas, R., Lajoie, M., Moldoveanu, D., Hoang, K. V., Lefrançois, P., Lingrand, M., Ahanfeshar-Adams, M., Watters, K. A., Spatz, A., Zippin, J. H., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0077-8 · Cited by 43
Chen, Q., Zhang, M., Pan, X., Yuan, X., Zhou, L., Yan, L., Zeng, L., Xu, J., Yang, B., Zhang, L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109740 · Cited by 40
Hou, J., He, Z., Liu, T., Chen, D., Wang, B., Wen, Q., & Zheng, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.755053 · Cited by 48
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens
Schlabach, M. R., Lin, S., Collester, Z. R., Wrocklage, C., Shenker, S., Calnan, C., Xu, T., Gannon, H., Williams, L. J., Thompson, F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163096 · Cited by 44
Validation of Synthetic CRISPR Reagents as a Tool for Arrayed Functional Genomic Screening
Tan, J., & Martin, S. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168968 · Cited by 39
Dawes, R., Lek, M., & Cooper, S. T. (2019) · npj Genomic Medicine · doi:10.1038/s41525-019-0081-z · Cited by 41
RNA as the stone guest of protein aggregation
Louka, A., Zacco, E., Temussi, P. A., Tartaglia, G. G., & Pastore, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa822 · Cited by 37
Krenning, L., Sonneveld, S., & Tanenbaum, M. E. (2022) · eLife · doi:10.7554/elife.71356 · Cited by 41
Recent advances in targeted protein degraders as potential therapeutic agents
Yang, N., Kong, B., Zhu, Z., Huang, F., Zhang, L., Lu, T., Chen, Y., Zhang, Y., & Jiang, Y. (2023) · Molecular Diversity · doi:10.1007/s11030-023-10606-w · Cited by 44
O-GlcNAcase Is an RNA Polymerase II Elongation Factor Coupled to Pausing Factors SPT5 and TIF1β
Resto, M., Kim, B., Fernandez, A. G., Abraham, B. J., Zhao, K., & Lewis, B. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751420 · Cited by 43
Zhang, S., Fan, G., Yuan, H., Hammell, M., Wilkinson, J. E., & Tonks, N. K. (2017) · Genes & Development · doi:10.1101/gad.304261.117 · Cited by 42
Evaluation and Design of Genome-wide CRISPR/Cas9 Knockout ScreensPreprint
Hart, T., Tong, A. H. Y., Chan, K., van Leeuwen, J. S., Seetharaman, A., Aregger, M., Chandrashekhar, M., Hustedt, N., Seth, S., Noonan, A. J. C., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/117341 · Cited by 41
CRISPR-Cas9: from Genome Editing to Cancer Research
Chen, S., Sun, H., Miao, K., & Deng, C. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.17421 · Cited by 40
Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells
Murmann, A. E., Gao, Q. Q., Putzbach, W., Patel, M., Bartom, E. T., Law, C., Bridgeman, B. B., Chen, S., McMahon, K. M., Thaxton, C. S., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745336 · Cited by 40
Zhu, J., Gong, R., Zhu, Q., He, Q., Xu, N., Xu, Y., Cai, M., Zhou, X., Zhang, Y., & Zhou, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-28217-z · Cited by 38
Systematic analysis reveals the prevalence and principles of bypassable gene essentiality
Li, J., Wang, H.-T., Wang, W.-T., Zhang, X., Suo, F., Ren, J.-Y., Bi, Y., Xue, Y.-X., Hu, W., Dong, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08928-1 · Cited by 43
The conditional nature of gene essentiality
Larrimore, K. E., & Rancati, G. I. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.07.015 · Cited by 39
STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers
van der Lelij, P., Newman, J. A., Lieb, S., Jude, J., Katis, V. L., Hoffmann, T., Hinterndorfer, M., Bader, G., Kraut, N., Pearson, M. A., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.202000725 · Cited by 40
Alford, J. S., Lampe, J. W., Brach, D., Chesworth, R., Cosmopoulos, K., Duncan, K. W., Eckley, S. T., Kutok, J. L., Raimondi, A., Riera, T. V., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00167 · Cited by 43
Endoplasmic Reticulum Membrane Contact Sites, Lipid Transport, and NeurodegenerationPreprint
Guillén-Samander, A., & Camilli, P. V. D. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041257 · Cited by 39
Moder, M., Velimezi, G., Owusu, M., Mazouzi, A., Wiedner, M., da Silva, J. F., Robinson-Garcia, L., Schischlik, F., Slavkovský, R., Královics, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01439-x · Cited by 44
Yu, Y., Hu, W., Xu, Y., Xu, H.-B., & Gao, J.-Q. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113719 · Cited by 44
Haploid Human Embryonic Stem Cells: Half the Genome, Double the Value
Yilmaz, A., Peretz, M., Sagi, I., & Benvenisty, N. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.10.009 · Cited by 40
Kanoje, B., Padsala, S., Parikh, J. K., Sahoo, S. K., Kuperkar, K. C., & Bahadur, P. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c7cp05917e · Cited by 39
Single-Cell Genomic Analysis in Plants
Yuan, Y., Lee, H., Hu, H., Scheben, A., & Edwards, D. (2018) · Genes · doi:10.3390/genes9010050 · Cited by 38
6mer seed toxicity in tumor suppressive microRNAs
Gao, Q. Q., Putzbach, W., Murmann, A. E., Chen, S., Sarshad, A. A., Peter, J. M., Bartom, E. T., Hafner, M., & Peter, M. E. (2018) · Nature Communications · doi:10.1038/s41467-018-06526-1 · Cited by 38
Yilmaz, A., Braverman-Gross, C., Bialer-Tsypin, A., Peretz, M., & Benvenisty, N. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.06.023 · Cited by 40
Genome-scale CRISPR screening at high sensitivity with an empirically designed sgRNA library
Henkel, L., Rauscher, B., Schmitt, B. A., Winter, J., & Boutros, M. (2020) · BMC Biology · doi:10.1186/s12915-020-00905-1 · Cited by 40
EVI1 drives leukemogenesis through aberrant ERG activation
Schmoellerl, J., Barbosa, I. A. M., Minnich, M., Andersch, F., Smeenk, L., Havermans, M., Eder, T., Neumann, T., Jude, J., Fellner, M., et al. (2022) · Blood · doi:10.1182/blood.2022016592 · Cited by 41
Goel, K., & Ploski, J. E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.914430 · Cited by 41
Lam, I., Ndayisaba, A., Lewis, A. J., Fu, Y., Sagredo, G. T., Kuzkina, A., Zaccagnini, L., Celikag, M., Sandoe, J., Sanz, R. L., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.06.002 · Cited by 37
den Eynden, J. V., & Larsson, E. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00074 · Cited by 34
Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy
Liu, C., Banister, C. E., & Buckhaults, P. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3024 · Cited by 39
OBF1 and Oct factors control the germinal center transcriptional program
Song, S., Cao, C., Choukrallah, M.-A., Tang, F., Christofori, G., Kohler, H., Wu, F., Fodor, B. D., Frederiksen, M. U., Willis, S. N., et al. (2021) · Blood · doi:10.1182/blood.2020010175 · Cited by 40
Long-read cDNA sequencing identifies functional pseudogenes in the human transcriptome
Troskie, R., Jafrani, Y., Mercer, T. R., Ewing, A. D., Faulkner, G. J., & Cheetham, S. W. (2021) · Genome biology · doi:10.1186/s13059-021-02369-0 · Cited by 41
An optimized genome-wide, virus-free CRISPR screen for mammalian cells
Xiong, K., Karottki, K. J. L. C., Hefzi, H., Li, S., Grav, L. M., Li, S., Spahn, P. N., Lee, J. S., Ventiņa, I., Lee, G. M., et al. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100062 · Cited by 38
Schiza, C., Korbakis, D., Jarvi, K. A., Diamandis, E. P., & Drabovich, A. P. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001170 · Cited by 38
Probing condensate microenvironments with a micropeptide killswitch
Zhang, Y., Stöppelkamp, I., Fernández‐Pernas, P., Allram, M., Charman, M., Magalhães, A. P., Piédavent, M., Sommer, G., Sung, Y.-C., Meyer, K., et al. (2025) · Nature · doi:10.1038/s41586-025-09141-5 · Cited by 37
Requirements for Comprehensive Pharmacogenetic Genotyping Platforms
Lauschke, V. M., & Ingelman‐Sundberg, M. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0023 · Cited by 37
Chen, Y., Bartanus, J., Liang, D., Zhu, H., Breman, A. M., Smith, J. L., Wang, H., Ren, Z., Patel, A., Stankiewicz, P., et al. (2017) · Human Mutation · doi:10.1002/humu.23207 · Cited by 40
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma
Hüllein, J., Slabicki, M. M., Rosołowski, M., Jethwa, A., Habringer, S., Tomska, K., Kurilov, R., Lu, J., Scheinost, S., Wagener, R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3438 · Cited by 38
Wang, B., Wang, Z., Wang, D., Zhang, B., Ong, S., Li, M., Yu, W., & Wang, Y. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0150-y · Cited by 37
Shen, J. L., Fortier, T. M., Zhao, Y. G., Wang, R., Burmeister, M., & Baehrecke, E. H. (2021) · Current Biology · doi:10.1016/j.cub.2021.04.062 · Cited by 36
Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells
Liu, T., Krysiak, K., Shirai, C. L., Kim, S. P., Shao, J., Ndonwi, M., & Walter, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170470 · Cited by 36
Emerging cancer-specific therapeutic aptamers
Yoon, S., & Rossi, J. J. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000389 · Cited by 36
CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions
Gebre, M. S., Nomburg, J., & Gewurz, B. E. (2018) · Viruses · doi:10.3390/v10020055 · Cited by 37
Impact of Genetic Variation on CRISPR-Cas Targeting
Canver, M. C., Joung, J. K., & Pinello, L. (2018) · The CRISPR Journal · doi:10.1089/crispr.2017.0016 · Cited by 36
Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma
Yoda, H., Inoue, T., Shinozaki, Y., Lin, J. C., Watanabe, T., Koshikawa, N., Takatori, A., & Nagase, H. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1198 · Cited by 36
Dong, C., Jin, Y.-T., Hua, H., Wen, Q., Luo, S., Zheng, W., & Guo, F. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby116 · Cited by 35
A Chemical Screen Identifies Compounds Capable of Selecting for Haploidy in Mammalian Cells
Olbrich, T., Vega-Sendino, M., Murga, M., de Cárcer, G., Malumbres, M., Ortega, S., Ruiz, S., & Fernández-Capetillo, Ó. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.060 · Cited by 43
Gabaev, I., Williamson, J. C., Crozier, T. W. M., Schulz, T. F., & Lehner, P. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108249 · Cited by 36
Somatic XIST activation and features of X chromosome inactivation in male human cancers
Sadagopan, A., Nasim, I. T., Li, J., Achom, M., Zhang, C., & Viswanathan, S. R. (2022) · Cell Systems · doi:10.1016/j.cels.2022.10.002 · Cited by 36
Genome-scale CRISPR screening in a single mouse liver
Keys, H. R., & Knouse, K. A. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100217 · Cited by 35
Zheng, R., Dunlap, M., Bobkov, G. O. M., Gonzalez‐Figueroa, C., Patel, K. J., Lyu, J., Harvey, S. E., Chan, T. W., Quinones-Valdez, G., Choudhury, M., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.05.004 · Cited by 44
Functional interrogation of non-coding DNA through CRISPR genome editing
Canver, M. C., Bauer, D. E., & Orkin, S. H. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.008 · Cited by 36
Ryu, J. Y., Kim, H. U., & Lee, S. Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713050114 · Cited by 34
Network Embedding the Protein–Protein Interaction Network for Human Essential Genes Identification
Dai, W., Chang, Q., Peng, W., Zhong, J., & Li, Y. (2020) · Genes · doi:10.3390/genes11020153 · Cited by 35
Reprogramming microbial populations using a programmed lysis system to improve chemical production
Diao, W., Guo, L., Ding, Q., Gao, C., Hu, G., Chen, X., Li, Y., Zhang, L., Chen, W., Chen, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27226-3 · Cited by 35
Tutorial: design and execution of CRISPR in vivo screens
Braun, C. J., Adames, A. C., Saur, D., & Rad, R. (2022) · Nature Protocols · doi:10.1038/s41596-022-00700-y · Cited by 38
Genome-wide CRISPR screens identify ILF3 as a mediator of mTORC1-dependent amino acid sensing
Yan, G., Yang, J., Li, W., Guo, A., Guan, J., & Liu, Y. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01123-x · Cited by 36
Chevallier, O., Zhou, N., He, J., Loffroy, R., & Wáng, Y. X. J. (2018) · Acta Radiologica · doi:10.1177/0284185118756949 · Cited by 34
Nunes, S., Bonyek-Silva, Í., Ampuero, M. R., de Noronha, A. L. L., de Souza, L. C. L., Correia, T. C., Khouri, R., Boaventura, V. S., Barral, A. M. P., Ramos, P. I. P., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00640 · Cited by 36
Simonovsky, E., Schuster, R., & Yeger‐Lotem, E. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz023 · Cited by 34
Transcriptional activity and strain-specific history of mouse pseudogenes
Sisu, C., Muir, P., Frankish, A., Fiddes, I. T., Diekhans, M., Thybert, D., Odom, D. T., Flicek, P., Keane, T., Hubbard, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17157-w · Cited by 36
Use of signals of positive and negative selection to distinguish cancer genes and passenger genes
Bányai, L., Trexler, M., Kerekes, K., Csuka, O., & Patthy, L. (2021) · eLife · doi:10.7554/elife.59629 · Cited by 36
Replication-dependent cytotoxicity and Spartan-mediated repair of trapped PARP1–DNA complexes
Saha, L. K., Murai, Y., Saha, S. T., Jo, U., Tsuda, M., Takeda, S., & Pommier, Y. G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab777 · Cited by 34
Fitness effects of CRISPR/Cas9-targeting of long noncoding RNA genes
Horlbeck, M. A., Liu, S. J., Chang, H. Y., Lim, D. A., & Weissman, J. S. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0428-0 · Cited by 34
Reduced O-GlcNAcase expression promotes mitotic errors and spindle defects
Lanza, C., Tan, E. P., Zhang, Z., Machacek, M. E., Brinker, A. E., Azuma, M., & Slawson, C. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1167297 · Cited by 33
Henser‐Brownhill, T., Monserrat, J., & Scaffidi, P. (2017) · Epigenetics · doi:10.1080/15592294.2017.1395121 · Cited by 33
Application of CRISPR genetic screens to investigate neurological diseases
So, R. W. L., Chung, S., Lau, H. H. C., Watts, J. J., Gaudette, E. V., Al‐Azzawi, Z. A. M., Bishay, J., Lin, L. T., Joung, J., Wang, X., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0343-3 · Cited by 37
Comprehensive host-pathogen protein-protein interaction network analysis
Khorsand, B., Savadi, A., & Naghibzadeh, M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03706-z · Cited by 33
Nie, M., Du, L., Ren, W., Joung, J., Ye, X., Shi, X., Ciftci, S., Liu, D., Wu, K., Zhang, F., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03695-8 · Cited by 35
Miliotou, Α. N., Pappas, I. S., Spyroulias, G. A., Vlachaki, E., Tsiftsoglou, A. S., Vizirianakis, I. S., & Papadopoulou, L. C. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.09.008 · Cited by 33
Ünlü, G., Prizer, B., Erdal, R., Yeh, H.-W., Bayraktar, E. C., & Birsoy, K. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.024 · Cited by 34
Self-citationMost cancers carry a substantial deleterious load due to Hill-Robertson interference
Tilk, S., Tkachenko, S., Curtis, C. N., Petrov, D. A., & McFarland, C. D. (2022) · eLife · doi:10.7554/elife.67790 · Cited by 37
Human Knockout Carriers: Dead, Diseased, Healthy, or Improved?
Narasimhan, V. M., Xue, Y., & Tyler‐Smith, C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.02.006 · Cited by 35
Identifying synthetic lethal targets using CRISPR/Cas9 system
Dhanjal, J. K., Radhakrishnan, N., & Sundar, D. (2017) · Methods · doi:10.1016/j.ymeth.2017.07.007 · Cited by 32
Tonekaboni, S. A. M., Mazrooei, P., Kofia, V., Haibe‐Kains, B., & Lupien, M. (2019) · Genome Research · doi:10.1101/gr.248658.119 · Cited by 32
Requirement for YAP1 signaling in myxoid liposarcoma
Trautmann, M., Cheng, Y., Jensen, P., Azoitei, N., Brunner, I., Hüllein, J., Slabicki, M., Isfort, I., Cyra, M., Berthold, R., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809889 · Cited by 32
A genetic basis for sex differences in Xp11 translocation renal cell carcinoma
Achom, M., Sadagopan, A., Bao, C., McBride, F., Li, J., Konda, P., Tourdot, R. W., Xu, Q., Nakhoul, M., Gallant, D. S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.038 · Cited by 35
Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer
Chen, M.-C., Tsai, Y.-C., Tseng, J.-H., Liou, J., Horng, S., Wen, H.-C., Fan, Y.-C., Zhong, W.-B., & Hsu, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122690 · Cited by 33
Role of duplicate genes in determining the tissue-selectivity of hereditary diseases
Barshir, R., Hekselman, I., Shemesh, N., Sharon, M., Novack, L., & Yeger‐Lotem, E. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007327 · Cited by 32
Wang, S., Crisman, L., Miller, J. L., Datta, I., Gulbranson, D. R., Tian, Y., Yin, Q., Yu, H., & Shen, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010821 · Cited by 31
Genomics-guided pre-clinical development of cancer therapies
Francies, H. E., McDermott, U., & Garnett, M. J. (2020) · Nature Cancer · doi:10.1038/s43018-020-0067-x · Cited by 32
dbGuide: a database of functionally validated guide RNAs for genome editing in human and mouse cells
Gooden, A. A., Evans, C. N., Sheets, T. P., Clapp, M. E., & Chari, R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa848 · Cited by 35
CRISPR screen in cancer: status quo and future perspectives.
He, C., Han, S., Chang, Y., Wu, M., Zhao, Y., Chen, C. Y., & Chu, X. (2021) · PubMed · Cited by 37
Path to improving the life cycle and quality of genome-scale models of metabolism
Seif, Y., & Palsson, B. Ø. (2021) · Cell Systems · doi:10.1016/j.cels.2021.06.005 · Cited by 26
Lenoir, W. F., Morgado, M. C., DeWeirdt, P. C., McLaughlin, M. E., Griffith, A. L., Sangree, A. K., Feeley, M. N., Anvar, N. E., Kim, E., Bertolet, L. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26867-8 · Cited by 31
Metadata
- Authors
- Wang, T., Birsoy, K., Hughes, N. W., Krupczak, K. M., Post, Y., Wei, J. J., Lander, E. S., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Lander, Eric S.
- Sabatini, David M.
- Venue
- Science
- Published
- 2015-11-27
- Volume
- 350
- Issue
- 6264
- Pages
- 1096-1101
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4662922
- OpenAlex
- W1934704664
- Cited by
- 1,617
- References
- 51
- Citations by year
- 2026: 60 · 2025: 103 · 2024: 116 · 2023: 147 · 2022: 146 · 2021: 199 · 2020: 182 · 2019: 171 · 2018: 182 · 2017: 193 · 2016: 104 · 2015: 10
- FWCI
- 70.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- National Institutes of Health (CA103866)
- Howard Hughes Medical Institute
- National Human Genome Research Institute (2U54HG003067-10)
- Massachussetts Institute of Technology Whitaker Health Sciences Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- essential genes, gene essentiality, CRISPR screen, single guide RNA library, cancer cell lines, RNA processing genes, nucleolus, cell proliferation and survival, cancer cell vulnerability, oncogenic drivers
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Cell Nucleolus, Genetic Testing, Humans, Neoplasms, RNA Processing, Post-Transcriptional, Genomic Library, Genome, Human, Genes, Essential, Gene Expression Profiling, Cell Line, Tumor, Gene Knockout Techniques, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review